Found 5 matching trials
Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis
PHASE1A single center, double-blind, randomized, dose-escalation study to assess ...
Location
Taipei Medical University
Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19
PHASE2AD17002 enhances nasal mucosal innate immunity and has met safety and effic...
Location
RSPI Sulianti Saroso
Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19
PHASE1AD17002 has demonstrated superior safety and efficacy as a nasal adjuvant f...
Location
Advagene Biopharma
AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
PHASE1This clinical trial aims to investigate patients with poorly controlled, mo...
Location
Taipei Medical University Hospital
A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma
PHASE21. Eosinophilic asthma, a type 2 immune disorder, often involves the excess...
Location
Advagene Biopharma